These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 384279)

  • 1. Renal sodium handling in cirrhosis: a reappraisal.
    Epstein M
    Nephron; 1979; 23(5):211-7. PubMed ID: 384279
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.
    Levy M; Wexler MJ
    J Lab Clin Med; 1978 Mar; 91(3):520-36. PubMed ID: 627753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deranged sodium homeostasis in cirrhosis.
    Epstein M
    Gastroenterology; 1979 Mar; 76(3):622-35. PubMed ID: 428715
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium retention in dogs with cirrhosis and ascites: efferent mechanisms.
    Levy M
    Am J Physiol; 1977 Dec; 233(6):F586-92. PubMed ID: 596456
    [No Abstract]   [Full Text] [Related]  

  • 5. Sodium retention and ascites formation in dogs with experimental portal cirrhosis.
    Levy M
    Am J Physiol; 1977 Dec; 233(6):F572-85. PubMed ID: 596455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
    Schrier RW; Arroyo V; Bernardi M; Epstein M; Henriksen JH; Rodés J
    Hepatology; 1988; 8(5):1151-7. PubMed ID: 2971015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of renal sodium handling in cirrhosis. A reappraisal.
    Epstein M
    Am J Nephrol; 1983; 3(6):297-309. PubMed ID: 6359883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of sodium retention in early cirrhosis of the liver: evidence for vascular overfilling.
    Levy M
    Semin Liver Dis; 1994 Feb; 14(1):4-13. PubMed ID: 8016661
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional relations between liver and kidney. I. Sodium excretion].
    Köhler H; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1988 Sep; 113(38):1486-91. PubMed ID: 2971522
    [No Abstract]   [Full Text] [Related]  

  • 10. The 'overflow' theory of ascites formation: a fading concept?
    Henriksen JH
    Scand J Gastroenterol; 1983 Oct; 18(7):833-7. PubMed ID: 6374865
    [No Abstract]   [Full Text] [Related]  

  • 11. Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.
    Domenicali M; Caraceni P; Giannone F; Pertosa AM; Principe A; Zambruni A; Trevisani F; Croci T; Bernardi M
    Gastroenterology; 2009 Jul; 137(1):341-9. PubMed ID: 19208344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiology of cirrhotic edema: a reexamination of the "underfilling" and "overflow" hypotheses.
    Norris SH; Buell JC; Kurtzman NA
    Semin Nephrol; 1987 Jun; 7(2):99-105. PubMed ID: 3629030
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.
    Lieberman FL; Ito S; Reynolds TB
    J Clin Invest; 1969 Jun; 48(6):975-81. PubMed ID: 5771197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.
    Martin PY; Ginès P; Schrier RW
    N Engl J Med; 1998 Aug; 339(8):533-41. PubMed ID: 9709047
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis.
    Levy M; Wexler MJ
    Am J Physiol; 1987 Oct; 253(4 Pt 2):F664-71. PubMed ID: 3661718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites.
    Unikowsky B; Wexler MJ; Levy M
    J Clin Invest; 1983 Nov; 72(5):1594-604. PubMed ID: 6630520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of ascites formation in cirrhosis of the liver.
    Gerbes AL
    Hepatogastroenterology; 1991 Oct; 38(5):360-4. PubMed ID: 1765351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease.
    Jiménez W; Clária J; Arroyo V; Rodés J
    J Gastroenterol Hepatol; 1992; 7(1):90-7. PubMed ID: 1543874
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal response to saline load in experimental liver disease.
    Mullane JF; Gliedman ML
    J Surg Res; 1970 Nov; 10(11):519-23. PubMed ID: 5489509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.